Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.

Hung TM, Wang HM, Kang CJ, Huang SF, Liao CT, Chan SC, Ng SH, Chen IH, Lin CY, Fan KH, Chang JT.

Oral Oncol. 2013 Feb;49(2):169-74. doi: 10.1016/j.oraloncology.2012.08.011. Epub 2012 Oct 12.

PMID:
23063613
2.

Lymph node standardized uptake values at pre-treatment 18F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.

Jeong Y, Baek S, Park JW, Joo JH, Kim JS, Lee SW.

Br J Radiol. 2017 Mar;90(1071):20160239. doi: 10.1259/bjr.20160239. Epub 2016 Dec 23.

3.

Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma.

Chen WH, Tang LQ, Zhang L, Chen QY, Guo SS, Liu LT, Fan W, Zhang X, Guo L, Zhao C, Cao KJ, Qian CN, Guo X, Xie D, Zeng MS, Mai HQ.

Oncotarget. 2015 Nov 10;6(35):38296-307. doi: 10.18632/oncotarget.5699.

4.

Prognostic value of primary gross tumor volume and standardized uptake value of 18F-FDG in PET/CT for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.

Jin YN, Yao JJ, Wang SY, Zhang WJ, Zhou GQ, Zhang F, Cheng ZB, Ma J, Mo HY, Sun Y.

Tumour Biol. 2017 Jul;39(7):1010428317717843. doi: 10.1177/1010428317717843.

PMID:
28671052
5.

Positron emission tomography-computed tomography before treatment is highly prognostic of distant metastasis in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy treatment: a prospective study with long-term follow-up.

Xiao W, Xu A, Han F, Lin X, Lu L, Shen G, Huang S, Fan W, Deng X, Zhao C.

Oral Oncol. 2015 Apr;51(4):363-9. doi: 10.1016/j.oraloncology.2015.01.009. Epub 2015 Feb 2.

PMID:
25655559
6.

Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.

Chan SC, Chang JT, Lin CY, Ng SH, Wang HM, Liao CT, Chang CJ, Lin SY, Yen TC.

Nucl Med Commun. 2011 Nov;32(11):989-96. doi: 10.1097/MNM.0b013e3283495662.

PMID:
21862944
7.

Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.

Zhang Y, Li WF, Mao YP, Zhou GQ, Peng H, Sun Y, Liu Q, Chen L, Ma J.

Oncotarget. 2016 Mar 22;7(12):13612-20. doi: 10.18632/oncotarget.7253.

8.

The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Liu WS, Wu MF, Tseng HC, Liu JT, Weng JH, Li YC, Lee JK.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):561-6. doi: 10.1016/j.ijrobp.2010.11.055. Epub 2011 Feb 6.

PMID:
21300483
9.
10.

Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.

Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM.

Dis Esophagus. 2017 Aug 1;30(8):1-10. doi: 10.1093/dote/dox021.

PMID:
28575243
11.

Prognostic impact of standardized uptake value of F-18 FDG PET/CT in nasopharyngeal carcinoma.

Chan WK, Kwong DL, Yeung DW, Huang B, Khong PL.

Clin Nucl Med. 2011 Nov;36(11):1007-11. doi: 10.1097/RLU.0b013e31821a29a4.

PMID:
21975389
12.

The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.

Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.

Eur J Cardiothorac Surg. 2013 Jul;44(1):83-7. doi: 10.1093/ejcts/ezs604. Epub 2012 Dec 11.

PMID:
23233074
13.

Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.

Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D.

Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24.

PMID:
28540535
14.

Is unenhanced 18F-FDG-PET/CT better than enhanced CT in the detection of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma?

Wu IS, Hung GU, Chang BL, Liu CK, Chang TH, Lee HS, Chen MK.

Ear Nose Throat J. 2016 Apr-May;95(4-5):178-84.

PMID:
27140019
15.

18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.

Song BI, Lee SW, Jeong SY, Chae YS, Lee WK, Ahn BC, Lee J.

J Nucl Med. 2012 Sep;53(9):1337-44. doi: 10.2967/jnumed.111.098640. Epub 2012 Jun 29.

16.

Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.

Chan SC, Chang JT, Wang HM, Lin CY, Ng SH, Fan KH, Chin SC, Liao CT, Yen TC.

Oral Oncol. 2009 Jan;45(1):52-8. doi: 10.1016/j.oraloncology.2008.03.010. Epub 2008 May 19.

PMID:
18487079
17.

Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.

Matsubara R, Kawano S, Chikui T, Kiyosue T, Goto Y, Hirano M, Jinno T, Nagata T, Oobu K, Abe K, Nakamura S.

Acad Radiol. 2012 Jun;19(6):708-17. doi: 10.1016/j.acra.2012.02.009. Epub 2012 Apr 7.

PMID:
22484437
18.

Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.

Huang Y, Feng M, He Q, Yin J, Xu P, Jiang Q, Lang J.

Medicine (Baltimore). 2017 Apr;96(17):e6721. doi: 10.1097/MD.0000000000006721. Review.

19.

[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.

Hsieh TC, Hsieh CY, Yang TY, Chen TT, Lin CY, Lin CC, Hua CH, Chiu CF, Yeh SP, Sher YP.

Oncologist. 2015 May;20(5):539-45. doi: 10.1634/theoncologist.2014-0291. Epub 2015 Apr 15.

20.

Pretreatment maximum standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography as a predictor of distant metastasis in adenoid cystic carcinoma of the head and neck.

Kim D, Kim W, Lee J, Ki Y, Lee B, Cho K, Kim S, Nam J, Lee J, Kim D.

Head Neck. 2016 May;38(5):755-61. doi: 10.1002/hed.23953. Epub 2015 May 26.

PMID:
25524466

Supplemental Content

Support Center